Edward White
Stock Analyst at HC Wainwright & Co.
(2.03)
# 2,907
Out of 4,742 analysts
356
Total ratings
31.4%
Success rate
-3.66%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VALN Valneva SE | Maintains: Buy | $19 → $18 | $4.74 | +279.75% | 31 | Jan 23, 2025 | |
| IFRX InflaRx | Reiterates: Buy | $8 | $2.37 | +237.55% | 23 | Jan 16, 2025 | |
| KPTI Karyopharm Therapeutics | Reiterates: Buy | $7 | $0.69 | +917.15% | 26 | Jan 15, 2025 | |
| DVAX Dynavax Technologies | Maintains: Buy | $29 → $31 | $12.80 | +142.19% | 20 | Jan 14, 2025 | |
| INZY Inozyme Pharma | Maintains: Buy | $14 → $16 | $1.32 | +1,112.12% | 12 | Jan 13, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $0.88 | - | 9 | Jan 10, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $4 | $0.53 | +654.72% | 5 | Jan 10, 2025 | |
| CMRX Chimerix | Reiterates: Buy | $11 | $3.83 | +187.21% | 16 | Dec 30, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $20 | $6.25 | +220.00% | 1 | Dec 30, 2024 | |
| PBYI Puma Biotechnology | Reiterates: Buy | $7 | $3.02 | +131.79% | 19 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.94 | - | 20 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.63 | +313.22% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $10.37 | +63.93% | 13 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.43 | +483.09% | 17 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $14.41 | +253.92% | 28 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $8.10 | +171.60% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.52 | - | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $29.04 | +89.39% | 29 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.58 | - | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $10.56 | +165.15% | 21 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $5 | $2.83 | +76.68% | 9 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $3.67 | +63.49% | 13 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.27 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.70 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.52 | +5,280.48% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $23.29 | +28.81% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.34 | +795.52% | 2 | Mar 6, 2018 |
Valneva SE
Jan 23, 2025
Maintains: Buy
Price Target: $19 → $18
Current: $4.74
Upside: +279.75%
InflaRx
Jan 16, 2025
Reiterates: Buy
Price Target: $8
Current: $2.37
Upside: +237.55%
Karyopharm Therapeutics
Jan 15, 2025
Reiterates: Buy
Price Target: $7
Current: $0.69
Upside: +917.15%
Dynavax Technologies
Jan 14, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $12.80
Upside: +142.19%
Inozyme Pharma
Jan 13, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $1.32
Upside: +1,112.12%
60 Degrees Pharmaceuticals
Jan 10, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Sensei Biotherapeutics
Jan 10, 2025
Reiterates: Buy
Price Target: $4
Current: $0.53
Upside: +654.72%
Chimerix
Dec 30, 2024
Reiterates: Buy
Price Target: $11
Current: $3.83
Upside: +187.21%
Artiva Biotherapeutics
Dec 30, 2024
Initiates: Buy
Price Target: $20
Current: $6.25
Upside: +220.00%
Puma Biotechnology
Dec 23, 2024
Reiterates: Buy
Price Target: $7
Current: $3.02
Upside: +131.79%
Dec 19, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.94
Upside: -
Dec 17, 2024
Reiterates: Buy
Price Target: $15
Current: $3.63
Upside: +313.22%
Dec 13, 2024
Reiterates: Buy
Price Target: $17
Current: $10.37
Upside: +63.93%
Dec 10, 2024
Reiterates: Buy
Price Target: $20
Current: $3.43
Upside: +483.09%
Dec 10, 2024
Reiterates: Buy
Price Target: $51
Current: $14.41
Upside: +253.92%
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $8.10
Upside: +171.60%
Nov 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.52
Upside: -
Nov 5, 2024
Maintains: Buy
Price Target: $49 → $55
Current: $29.04
Upside: +89.39%
Oct 24, 2024
Initiates: Neutral
Price Target: n/a
Current: $7.58
Upside: -
Oct 16, 2024
Reiterates: Buy
Price Target: $28
Current: $10.56
Upside: +165.15%
Oct 14, 2024
Maintains: Buy
Price Target: $15 → $5
Current: $2.83
Upside: +76.68%
Aug 12, 2024
Reiterates: Buy
Price Target: $6
Current: $3.67
Upside: +63.49%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.27
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.52
Upside: +5,280.48%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $23.29
Upside: +28.81%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.34
Upside: +795.52%